Overview
Won Lee practices in Seoul, Republic of Korea. Mr. Lee is rated as an Experienced expert by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Central Serous Chorioretinopathy, Vitrectomy, and Lithotripsy.
His clinical research consists of co-authoring 166 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Geographic Atrophy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adult-Onset Vitelliform Macular Dystrophy (AVMD)
- Age-Related Macular Degeneration (ARMD)
- Central Serous Chorioretinopathy
- CMV RetinitisMr. Lee isAdvanced. Learn about CMV Retinitis.
- Late-Onset Retinal Degeneration
- VitrectomyMr. Lee isAdvanced. Learn about Vitrectomy.
- Experienced
- Cataract RemovalMr. Lee isExperienced. Learn about Cataract Removal.
- Cerebral HypoxiaMr. Lee isExperienced. Learn about Cerebral Hypoxia.
- Cytomegalic Inclusion DiseaseMr. Lee isExperienced. Learn about Cytomegalic Inclusion Disease.
- Cytomegalovirus InfectionMr. Lee isExperienced. Learn about Cytomegalovirus Infection.
- Diabetic Macular Edema (DME)Mr. Lee isExperienced. Learn about Diabetic Macular Edema (DME).
- Diabetic RetinopathyMr. Lee isExperienced. Learn about Diabetic Retinopathy.